Viewing Study NCT00363051

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:49 PM
Ignite Modification Date: 2026-04-11 @ 9:53 AM
Study NCT ID: NCT00363051
Status: COMPLETED
Last Update Posted: 2013-05-10
First Post: 2006-08-02
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Islet Cell Carcinoma View
None Neuroendocrine Carcinoma View
None Neuroendocrine Tumor View
None Pancreatic Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pancreatic View
None Tumor View
None Islet Cell View
None Carcinoma View
None Neuroendocrine View
None Endocrine View
None Atypical Carcinoid View
None RADIANT1 View
None RADIANT-1 View